tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2020 Oct 29;1-11.
doi: 10.1080/21645515.2020.1810496. Online ahead of print.
Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic
Sukhadeo Baliram Barbuddhe[SUP] 1 [/SUP], Deepak Bhiwa Rawool[SUP] 1 [/SUP], Pankaj Prakash Gaonkar[SUP] 1 [/SUP], Jess Vergis[SUP] 2 [/SUP], Kuldeep Dhama[SUP] 3 [/SUP], Satyaveer Singh Malik[SUP] 4 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathlessness, fatigue and malaise; however, cutaneous, ocular, neurological, and gastrointestinal manifestations have also been reported. There is an urgent need to strengthen One Health surveillance, intervention, and management strategies to understand the ecology of coronaviruses and to prevent epidemics in the future. Global attention toward the development of treatments, immunotherapies, vaccines, and control options to combat the COVID-19 pandemic has been on an increasing trend. Here, we review the current epidemiological status, public health concerns, and mitigation strategies for COVID-19.
Keywords: COVID 19; Global Scenario; epidemiology; immunotherapeutics; vaccines.
. 2020 Oct 29;1-11.
doi: 10.1080/21645515.2020.1810496. Online ahead of print.
Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic
Sukhadeo Baliram Barbuddhe[SUP] 1 [/SUP], Deepak Bhiwa Rawool[SUP] 1 [/SUP], Pankaj Prakash Gaonkar[SUP] 1 [/SUP], Jess Vergis[SUP] 2 [/SUP], Kuldeep Dhama[SUP] 3 [/SUP], Satyaveer Singh Malik[SUP] 4 [/SUP]
Affiliations
- PMID: 33121328
- DOI: 10.1080/21645515.2020.1810496
Abstract
Severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathlessness, fatigue and malaise; however, cutaneous, ocular, neurological, and gastrointestinal manifestations have also been reported. There is an urgent need to strengthen One Health surveillance, intervention, and management strategies to understand the ecology of coronaviruses and to prevent epidemics in the future. Global attention toward the development of treatments, immunotherapies, vaccines, and control options to combat the COVID-19 pandemic has been on an increasing trend. Here, we review the current epidemiological status, public health concerns, and mitigation strategies for COVID-19.
Keywords: COVID 19; Global Scenario; epidemiology; immunotherapeutics; vaccines.